StockWatch
·

Tatva Chintan Pharma Chem Ltd Q4 FY26 Results

TATVAQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue134.142.1%24.4%
Total Income133.800.6%23.2%
Expenditure117.211.6%10.0%
PBT16.596.1%718.3%
Net Profit10.3231.9%902.0%
OPM20.97%1.57pp12.67pp
NPM7.71%3.69pp6.76pp
EPS4.4132.0%902.3%
View full financials

Informational and educational content only. Not investment advice.